Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (70)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Turesson, C.
Right arrow Articles by Bergstrom, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turesson, C.
Right arrow Articles by Bergstrom, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology, Vol 38, 668-674, Copyright © 1999 by British Society for Rheumatology


ORIGINAL PAPERS

Extra-articular rheumatoid arthritis: prevalence and mortality

C Turesson, L Jacobsson and U Bergstrom
Department of Rheumatology, Lund University, University Hospital, Malmo, Sweden.

OBJECTIVE: The prevalence and distribution of extra-articular manifestations of rheumatoid arthritis (ExRA) and associated mortality were studied retrospectively in a cohort of RA patients admitted to University Hospital, Malmo, Sweden, during the period 1990-94. RESULTS: Of 489 patients who fulfilled the 1987 ACR criteria for RA, 37 manifested onset of ExRA, predominantly serositis and cutaneous vasculitis, during the period, corresponding to a cumulative incidence of 7.9%. The occurrence of ExRA was independent of disease stage. Among patients with ExRA, 1 death/4.3 person-years at risk (pyr) occurred, as compared with 1 death/11.4 pyr in the non-ExRA subgroup. The age- and sex-adjusted mortality rate ratio was 2.49 (95% confidence interval 1.43-4.03). The major cause of death among ExRA cases was heart disease, which occurred in 9/13 cases (69%) in comparison to the expected 2.4 cases. CONCLUSION: In this series, serositis and cutaneous vasculitis were predominant extra-articular manifestations of RA; and mortality was greater in the ExRA than in the non-ExRA subgroup, perhaps due to a high frequency of associated heart disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. Bernatsky, A. E. Clarke, and S. Suissa
Hematologic Malignant Neoplasms After Drug Exposure in Rheumatoid Arthritis
Arch Intern Med, February 25, 2008; 168(4): 378 - 381.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
A. A. Mangi and D. F. Torchiana
Pericardial Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1465 - 1478.
[Full Text]


Home page
Ann Rheum DisHome page
T. M Farragher, M. Lunt, D. K Bunn, A. J Silman, and D. P M Symmons
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register
Ann Rheum Dis, April 1, 2007; 66(4): 486 - 492.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Turesson, L. Jacobsson, A. Ryden Ahlgren, G. Sturfelt, P. Wollmer, and T. Lanne
Increased stiffness of the abdominal aorta in women with rheumatoid arthritis
Rheumatology, July 1, 2005; 44(7): 896 - 901.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Sany, P Bourgeois, A Saraux, S Durieux, A Lafuma, J P Daures, F Guillemin, and J Sibilia
Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists
Ann Rheum Dis, October 1, 2004; 63(10): 1235 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. J. Goodson, A. J. Silman, D. J. Pattison, M. Lunt, D. Bunn, R. Luben, N. Day, K.-T. Khaw, and D. P. M. Symmons
Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis
Rheumatology, June 1, 2004; 43(6): 731 - 736.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. L. Matteson, C. M. Weyand, J. W. Fulbright, T. J. H. Christianson, R. L. McClelland, and J. J. Goronzy
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial
Rheumatology, May 1, 2004; 43(5): 619 - 625.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Turesson, W M O'Fallon, C S Crowson, S E Gabriel, and E L Matteson
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years
Ann Rheum Dis, August 1, 2003; 62(8): 722 - 727.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M.-M. Gordon, C. Buck, and R. Madhok
Inflammatory arthritis presenting as scrotal pain
Rheumatology, August 1, 2003; 42(8): 1003 - 1005.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Nakajima, O. Goek, X. Zhang, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand
De Novo Expression of Killer Immunoglobulin-Like Receptors and Signaling Proteins Regulates the Cytotoxic Function of CD4 T Cells in Acute Coronary Syndromes
Circ. Res., July 25, 2003; 93(2): 106 - 113.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
L Unger, M Kayser, and H G Nusslein
Successful treatment of severe rheumatoid vasculitis by infliximab
Ann Rheum Dis, June 1, 2003; 62(6): 587 - 588.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
A. A. Mangi and D. F. Torchiana
Pericardial Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 1359 - 1372.
[Full Text]


Home page
Ann Rheum DisHome page
E Lindqvist, T Saxne, P Geborek, and K Eberhardt
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage
Ann Rheum Dis, December 1, 2002; 61(12): 1055 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R Peltomaa, L Paimela, H Kautiainen, and M Leirisalo-Repo
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis
Ann Rheum Dis, October 1, 2002; 61(10): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Kuuliala, K Eberhardt, A Takala, H Kautiainen, H Repo, and M Leirisalo-Repo
Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study
Ann Rheum Dis, March 1, 2002; 61(3): 242 - 246.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M-M Gordon, E A Thomson, R Madhok, and H A Capell
Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study
Ann Rheum Dis, January 1, 2002; 61(1): 66 - 69.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Turesson, P. Englund, L. T. H. Jacobsson, G. Sturfelt, L. Truedsson, I. Nennesmo, and I. E. Lundberg
Increased endothelial expression of HLA-DQ and interleukin 1{alpha} in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle
Rheumatology, December 1, 2001; 40(12): 1346 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Takemura, P. A. Klimiuk, A. Braun, J. J. Goronzy, and C. M. Weyand
T Cell Activation in Rheumatoid Synovium Is B Cell Dependent
J. Immunol., October 15, 2001; 167(8): 4710 - 4718.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
R. F. Oien, A. Hakansson, and B. U. Hansen
Leg ulcers in patients with rheumatoid arthritis--a prospective study of aetiology, wound healing and pain reduction after pinch grafting
Rheumatology, July 1, 2001; 40(7): 816 - 820.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.